chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client stated she began to feel fatigued following administration of  the vaccine.  Fire Rescue at scene to evaluate the client.  All vitals within normal limits.  Client began to feel better.  Per Fire Rescue no further evaluation needed.  Client exited the site at 3:27pm.
difficult in climbling chair, squatting and getting up from the chair; swollen hands; Increased pain in shoulders,hands.; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Increased pain in shoulders,hands.), PERIPHERAL SWELLING (swollen hands), MOVEMENT DISORDER (difficult in climbling chair, squatting and getting up from the chair) and MYALGIA (Muscle pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Medical history was not provided.  Concomitant products included VITAMIN D3 from 16-Mar-2021 to an unknown date for Vitamin D deficiency.    On 29-Mar-2021 at 1:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Increased pain in shoulders,hands.) and MYALGIA (Muscle pain). On 12-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen hands). On an unknown date, the patient experienced MOVEMENT DISORDER (difficult in climbling chair, squatting and getting up from the chair). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Increased pain in shoulders,hands.), PERIPHERAL SWELLING (swollen hands) and MYALGIA (Muscle pain) had not resolved and MOVEMENT DISORDER (difficult in climbling chair, squatting and getting up from the chair) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Vitamin D: 29 (Low) low.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA 1273 with the events was considered as not applicable.  Patient reported that he had his appointment with PA on 18 June to repeat the blood work.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jun-2021: Follow-up document received. Added reporter information, patient demographics(age, height, weight, race and ethnic group),laboratory details, concomitant medication, new events( peripheral swelling and moment disorder).
Painful tingly sensation in left arm from shoulder all the ay to fingers./Pain under armpit and inside of elbow and wrist; Painful tingly sensation in left arm from shoulder all the ay to fingers.; I feel like I might have a panic attack/Feels like arm is asleep/This is terribly frightening and uncomfortable./I'm so scared; Pain under armpit and inside of elbow and wrist; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jan2022 15:15 (Batch/Lot number: unknown) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing), notes: Known allergies:No. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2), for COVID-19 Immunization; Bnt162b2 (Dose Number: 1), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 08Jan2022 22:00, outcome "not recovered", described as "Painful tingly sensation in left arm from shoulder all the ay to fingers./Pain under armpit and inside of elbow and wrist"; PARAESTHESIA (non-serious) with onset 08Jan2022 22:00, outcome "not recovered", described as "Painful tingly sensation in left arm from shoulder all the ay to fingers."; FEELING ABNORMAL (non-serious) with onset 08Jan2022 22:00, outcome "not recovered", described as "I feel like I might have a panic attack/Feels like arm is asleep/This is terribly frightening and uncomfortable./I'm so scared"; AXILLARY PAIN (non-serious) with onset 08Jan2022 22:00, outcome "not recovered", described as "Pain under armpit and inside of elbow and wrist". Therapeutic measures were not taken as a result of pain in extremity, paraesthesia, feeling abnormal, axillary pain.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has not been tested for COVID-19. It was reported that, The patient felt like The patient might have a panic attack. The patient took a clonazepam a few minutes ago. Her whole arm has been tingly like he hit a nerve all the way to her fingers. It was horrible like prickly and asleep. The arm that got the shot. Her armpit and inside of elbow and wrist on that arm have actual pain. The patient so scared. It was a painful tingly for maybe 8 hours now. Her whole hand and everything what was wrong with her. But it did not start immediately after the injection it took a couple of hours so the patient don't think he hit a nerve with a needle. Optional Information: Patient may have autoimmune disorder.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt reports he received his first dose of the Moderna series on 08/06/2021. On 08/07/2021, had difficulty swallowing due to pain, hurt to touch his teeth together, had very sensitive gums, and pain in his lips. Appeared that he had developed blisters with clear fluid on the sides of his tongue, inside his cheeks and lips, and on the roof of his mouth. States he went to the dentist on 08/09/2021 or 08/10/2021 and the blisters "turned white" by the time he arrived. His dentist prescribed him  but he did not get it because it was too expensive. States he has been swishing salt water and that his blisters have improved, though he still has some open blisters on the inside of his lips. Pt states he is able to eat and drink again. Pt is unsure if the blisters are related to the vaccine, but he has not had any new foods, medications, or supplements, and the vaccine was the only thing that was different.
This initial spontaneous report was received on 15-JAN-2019 from a 75 year old male patient referring to himself. The patient wished to remain anonymous and did not wish to provide any information regarding medical history, concurrent conditions, or concomitant medications. In approximately 2007 (reported as 12 years ago), the patient received ZOSTAVAX (dose, route, and lot # not reported. He stated that he is still suffering from unspecified nerve pain associated with the receipt of the vaccination. (onset date of the nerve pain not specified). The nerve pain has continuously been treated with gabapentin. The patient's present status was not recovered.  Causality assessment was related. The patient mentioned that he had retained or was in the process of retaining a lawyer to issue a lawsuit against the Company for the adverse effects he sustained following vaccination with ZOSTAVAX.
Soreness, swelling, redness, tiredness, chills, muscle pain in arm...still sore 2 days later
SWEATING; INJECTION SITE WARMTH; CHILLS; INJECTION SITE SWELLING; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.  The batch number was not reported. The Company is unable to perform follow-up to request batch/lot number No concomitant medications were reported. On an unspecified date, the subject experienced sweating, injection site warmth, chills, injection site swelling, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue, sweating, chills, injection site swelling and injection site warmth was not reported. This report was non-serious.
Temp 102.0, muscle and joint pain, coughing, headache Tested positive for COVID on 1/2/2021
About 30 minutes prior to admission to ER (20:00) patient began shaking limbs for 10 seconds 3-4 times within 30 minutes. Experienced seizure activity in ER lasting about 10 seconds 2-3 times. Dx acute febrile episode to immunizations. Temperature in ER 100, at home 100.
tiredness; muscle ache; chills; This is a spontaneous report from a contactable physician (patient, reported for herself). A 30-years-old female patient (who was not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EK5730, Expiration date: unknown), dose 1 via an unspecified route of administration, in Arm Left on 21Dec2020 15:00 (at the age of 30-years-old) as single for covid-19 immunisation. Patient also received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3246, Expiration date: unknown) via an unspecified route of administration, in Arm Left on 11Jan2021 15:00 ((at the age of 30-years-old) as single for covid-19 immunisation. The patient medical history included asthma. The patient concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19, Prior to vaccination. The patient has been tested for COVID-19, Since the vaccination. It was reported that after first shot of vaccination on an unknown date the patient had experienced tiredness, muscle ache and chills for about 20 hours. The patient took second shot on 11Jan2021, no adverse reactions were experienced. However, the patient had concerns in regards if Pfizer Covid vaccines were effective on her. She had an antibody testing on 27Jan2021 with SARS-CoV-2 Abbotts antibody kit and Vitalix nasal swab test with a reported IgG antibody test that has 99.63% specificity and 100% sensitivity that was completely negative at 16 days following the second dose of Pfizer COVID-19 vaccine, and she had the first dose exactly three weeks prior. She had read information from Pfizer indicating that its vaccine exhibits a robust induction of antibody response. Hence, she wanted to get advice from Pfizer on how to proceed with her concern as a health care provider who is constantly exposed to the virus and was wondering if re-vaccination would be advised. There was no treatment provided as a result of events. The patient underwent lab tests and procedures which included SARS-CoV-2 Abbotts antibody kit and Vitalix nasal swab test on 27Jan2021. The outcome of the events was unknown. The events were considered as non-serious by the reporter.  Follow-up attempts are completed. No further information is expected.
I did not lose smell or taste, I would go from 104 to 94 every few hours with no meds, sweating, constant cough, mucus phlegm in lungs, could not sleep on stomach or back if I laid down I would wheeze. I had constant cough for 4-5 days
This social media report (initial receipt: 04-Jun-2012) concerns a 7-year-old female patient. On ??-Dec-2011 the patient received her fatal dose of flu vaccine (manufacturer, brand name and batch number were not reported) and was pronounced dead about 92 hours later on 06-Dec-2011. The cause of death was not reported.
Significant swelling of the left shoulder/deltoid area with erythema and tenderness. Some limitation of movement. No systemic signs.
Bullous Pemphigoid. widespread, ongoing, Treatment with oral prednisone, topical steroid cream.
Patient given DTaP vaccine at 10:30am physical on 12-8-09. Patient came back to office at 3pm for possible immunization reaction. At that time patient had a 7 1/2cm x 7cm circular area of mild swelling and erythema. No pain. Treatment: cool compresses, Benadryl PRN and call back if worsen reaction.
I have pain underneath my arm and going down my side; It was very painful; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, unknown manufacturer), for COVID-19 immunization. The following information was reported: AXILLARY PAIN (non-serious), outcome "unknown", described as "I have pain underneath my arm and going down my side; It was very painful".  Additional information: Clinical course: It was reported that patient got second covid vaccine on Wednesday and have pain underneath arm and going downside is all that wanted to know. Patient do not know if that was a normal side effect or what. It was very painful.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My periods started on April 17 as it should but it never stopped. I am bleeding for 16 days now and usually, only 4 days. I?m not stressed or anything so it can seriously be related to the vaccine.
My leg muscles, in my thigh specifically, are very sore all the time. Occasionally, the muscles on the back of my leg are sore as well to the point that it hurts to sit down and I have to ?catch myself? with my hands to avoid using my leg muscles to sit. This is unresolved.   Additionally, my menstrual cycle immediately following my second shot was late by 3 days (I?m always on time). This was resolved by my next cycle.
Initial pregnancy report received from a healthcare professional on 05 September 2013: A 28-year-old female patient, whose medical history and concomitant medications were not reported, had received intramuscular first dose of ADACEL, lot number: C4432AB and expiry date: 18 October 2015 (anatomical site of administration not reported) on 05 September 2013. The patient's health during pregnancy, specific risk factors (e.g. : alcohol, tobacco or recreational drugs) was not reported. The patient was pregnant at the time of vaccination. The patient's date of last menstrual period was reported as 01 January 2013 and the expected date of delivery is 08 October 2013. At the time of the report, the patient had not experienced any adverse events. Documents held by sender: none.
My right foot balled up muscle spasms and body twitching daily headaches painful chest around my heart.
Started with headache, moved quickly to temperature of 102.7, numbness in face, chills, severe chest pain, heart racing at 131bmp though I was laying down, difficulty breathing, nausea, difficulty swallowing, extreme fatigue, paralysis of arms, hands, legs, feet, inability to speak or move mouth to form words.  All of these things occured within 30 minutes of starting, from 1:30-2:00pm.  Ambulance was called for me as I was unable to breathe well or speak, losing consciousness.
p/vax pt exp rapid heart beat (palpitation);extreme sweating; sore inner rt ear; very sore throat started; sore arm (inj site)
Pt rec'd DTaP, Prevnar, Flu vaccine and Synagis. developed erythema multiforme 1/13/02. On 1/15/02 pt presented to office. Tx Atarax improved.
blood clot in lower leg; achy; Pain in the back of leg that would not go away; body ache/ache; headache; A spontaneous report was received from a consumer  concerning a patient age ,57 years old male patient who developed Blood clot in lower leg/Thrombosis, Body ache/Myalgia, Headache/Headache and pain in the back of the leg that would not go away/pain in extremity.   The patient's medical history included Central Retinal vein occlusion (CRVO).  Concomitant product use was not provided/unknown by the reporter.   The patient received their first of two planned doses of mRNA-1273 (Batch number not provided) on unknown date.   The patient received their second of two planned doses of mRNA-1273 (Batch number not provided) on 03 Feb 2021, intramuscularly in the (unknown injection site) for prophylaxis of COVID-19 infection.    On the same day as receiving the vaccine 03 Feb 2021 patient reported as having pain in back of the leg that would not go away. Patient also had body aches, felt achy and had headache. Patient went to Emergency room on 03 Feb 2021 and was diagnosed a blood clot in lower leg. The event blood clot in lower leg was assessed as medically significant based on IME list.  Treatment information was not provided/unknown. Patient is following up with a hematologist.   The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  The outcome of the event(s), Blood clot in lower leg/Thrombosis, Body ache/Myalgia, Headache/Headache and pain the was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events (pain, myalgia, and headache) a causal relationship cannot be excluded. A very limited information regarding these event (Thrombosis) has been provided at this time. Noting the history of central retinal vein occlusion may remain as a risk factor for thrombosis. Further information has been requested.
69 expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (69 expired doses administered). On 11-Jan-2022, EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The LOT 012H21B vials were placed in refrigerator on 6-Dec-2021. The vaccine was used past 30-day use by date. No treatment medications was reported.   This case was linked to MOD-2022-448109, MOD-2022-449740, MOD-2022-449524 (Patient Link).
This case was reported by a physician via call center representative and described the occurrence of fever in a adult patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever. The patient was treated with ibuprofen. On an unknown date, the outcome of the fever was recovered/resolved. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The physician reported on online chat that the patient received SHINGRIX at a pharmacy and had fever for one day which resolved with ibuprofen. The physician did not provide any other information.
pt recv vax & Anti-HBS testing on 25MAR94 revealed neg results; No further details were provided;
Urticaria after 1.5 hours of injection. Benadryl given with significant decrease of urticaria.
Finger Injury; This spontaneous case was reported by a consumer and describes the occurrence of LIMB INJURY (Finger Injury) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced LIMB INJURY (Finger Injury). At the time of the report, LIMB INJURY (Finger Injury) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment drugs were not provided concomitant drugs were not provided
received first dose moderna june 26,and never received second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received first dose moderna june 26,and never received second dose yet) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (received first dose moderna june 26,and never received second dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (received first dose moderna june 26,and never received second dose yet) had resolved.            Concomitant product information was not provided. Treatment information was not provided.   Reporter did not allow further contact
Mother states child had fever off and on until 3/26/98. She gave Tylenol and Motrin off and on for the fever. On 3/26/98, fever up to 106.7 and child had a seizure. Child was taken to hospital and was hospitalized for 1 week. Child also, had excessive crying and "aching" prior to 3/26/98 and after 3/9/98 but didn't know what they were.
Patient reports that the next day after the PFIZER vaccine, she starts her period for 5 days and it was not supposed to have it by that time. Bleeding stops and comes back for 7 days again for additional 5 days. Stops for another 7 days and comes back for 5 more days. Patient reports that the bleeding was so profuse that she noticed it the entire area where she was sitting bled. Patient reports bleeding still, and the blood is very dark with solid clots. Patient reports heat sensation at night which is not usual. Patient communicates with her gynecologist/OBG who tells her to go to the hospital. Patient refers that she does not want to visit the hospital since she does not present any additional symptoms to bleeding. The patient is recommended to visit her specialist.
pt. having difficulty - swallowing, redness noted on tongue; no swelling; exp. wheezing noted  50 mg benadryl IM right thigh at 1450- Epi given at 1500 after pt. noted to have exp & insp wheezing.  Ambulance called & transported to hospital
Minor rash on left forearm; This is a spontaneous report from a contactable consumer (patient) received via Agency. A 51-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm, on 03Mar2021 at 09:15 (Lot Number: EL3248) (at the age of 51 years old) as dose 1, single for COVID-19 immunisation in a workplace clinic. Medical history included asthma. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has no known allergies. Concomitant medications included low-dose aspirin (acetylsalicylic acid) and an unspecified multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Mar2021, the patient experienced minor rash on left forearm. Rash did not appear anywhere else on the body. Rash appeared to be going away. The patient did not receive any treatment for the event. The patient was recovering from the event on the time of the report.  No follow-up attempts are needed. No further information is expected.
I asked for regular dose and  not the high dose. I was given the high dose anyway. 30 minutes later I had rapid heart beat, light headed and my fingers wouldn't work right. I was OK after a few hours but the rapid heartbeat continued all day.